Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Praxis Medicines

Dare for MORE™

## Sitemaps

- [XML Sitemap](https://praxismedicines.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Pages

- [Home](https://praxismedicines.com/) - DAREFORMORE® We dare for more in every aspect of what we do – advancing our portfolio of precision therapies for central nervous system disorders – to make the impossible possible. Learn About Our Methodology The field of neurology has been primed for a revolution in how new therapies are discovered. We have taken the
- [Clinical Trials](https://praxismedicines.com/clinical-trials/) - Clinical Trials Explore Our Clinical Research Programs Learn about ongoing and completed clinical studies related to investigational therapies for CNS disorders, including DEEs, epilepsies, and essential tremor. Resilience Program for children diagnosed with early-onset SCN2A or SCN8A DEE Recruitment Complete for children and adults diagnosed with any DEE and related syndrome Recruitment Complete for children
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES ПОВІДОМЛЕННЯ ПРО КОНФІДЕНЦІЙНІСТЬ PRAXIS eDIARY Останнє оновлення: 8 травня 2026 р. У цьому Повідомленні про конфіденційність описано, як Praxis Precision Medicines, Inc. («ми», «нас», «наш») збирає, використовує та розкриває інформацію про вас, коли ви користуєтеся Praxis eDiary («Додаток»). Для цілей цього Повідомлення про конфіденційність «ви» та «ваш» означають вас як
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES PRAXIS eDIARY GİZLİLİK BİLDİRİMİ Son Güncelleme: 8 Mayıs 2026 Bu Gizlilik Bildirimi içerisinde, Praxis eDiary’yi (“Uygulama”) kullanımınız sırasında Praxis Precision Medicines, Inc. (“biz”, “bize”, “bizim”) tarafından hakkınızdaki bilgilerin nasıl toplandığı, kullandığı ve açıkladığı ortaya konmaktadır. Bu Gizlilik Bildiriminin amaçları bakımından “siz” ve “sizin”, Uygulama kullanıcısı olarak sizi ifade eder. Bu
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES AVISO DE PRIVACIDAD DEL DIARIO ELECTRÓNICO DE PRAXIS Última actualización: 8 de mayo de 2026 En este Aviso de privacidad se describe cómo Praxis Precision Medicines, Inc. (“nosotros”, “nos”, “nuestro”) recopila, usa y divulga información sobre usted cuando utiliza el diario electrónico (la “Aplicación”) de Praxis. A los efectos de este Aviso
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES AVISO DE PRIVACIDAD DEL DIARIO ELECTRÓNICO DE PRAXIS Última actualización: 8 de mayo de 2026 En este Aviso de privacidad se describe cómo Praxis Precision Medicines, Inc. («nosotros», «nos», «nuestro») recopila, utiliza y divulga información sobre usted cuando utiliza el diario electrónico (la «Aplicación») de Praxis. A efectos de este Aviso de
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES OBAVEŠTENJE O PRIVATNOSTI ZA PRAXIS eDIARY Poslednji put ažurirano: 8. maj 2026. Ovo Obaveštenje o privatnosti opisuje kako Praxis Precision Medicines, Inc. („mi“, „nas“, „naš“) prikuplja, koristi i otkriva informacije o vama kada koristite Praxis eDiary („Aplikacija“). Za potrebe ovog Obaveštenja o privatnosti, „vi“ i „vaš“ označavaju vas kao korisnika
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES УВЕДОМЛЕНИЕ О КОНФИДЕНЦИАЛЬНОСТИ PRAXIS eDIARY Последнее обновление: 8 мая 2026 г. В настоящем Уведомлении о конфиденциальности описывается, как Praxis Precision Medicines, Inc. («мы», «нас», «наш») собирает, использует и раскрывает информацию о вас, когда вы используете Praxis eDiary («Приложение»). В целях настоящего Уведомления о конфиденциальности «вы» и «ваш» означают вас как
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES NOTIFICARE DE CONFIDENȚIALITATE PRAXIS eDIARY Ultima actualizare: 8 mai 2026 Această Notificare de confidențialitate descrie modul în care Praxis Precision Medicines, Inc. („noi”, „nouă”, „al nostru/a noastră”) colectează, utilizează și divulgă informații despre dvs. atunci când utilizați Praxis eDiary („Aplicația”). În sensul prezentei Notificări de confidențialitate, „dvs.” și „al dvs./a
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES AVISO DE PRIVACIDADE DA PRAXIS eDIARY Última Atualização: 8 de maio de 2026 Este Aviso de Privacidade descreve a forma como a Praxis Precision Medicines, Inc. (“nós”, “nos”, “nos”) recolhe, utiliza e divulga informações sobre si quando utiliza a Praxis eDiary (a “Aplicação”). Para efeitos do presente Aviso de Privacidade,
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES AVISO DE PRIVACIDADE DO PRAXIS eDIARY Última atualização: 8 de maio de 2026 Este Aviso de Privacidade descreve como a Praxis Precision Medicines, Inc. (“nós”, “nos”, “nosso(s)/nossa(s)”) coleta, usa e divulga informações sobre você quando você usa o Praxis eDiary (o “Aplicativo”). Para os fins deste Aviso de Privacidade, “você”
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES INFORMACJA O OCHRONIE PRYWATNOŚCI UŻYTKOWNIKA eDZIENNICZKA FIRMY PRAXIS Ostatnia aktualizacja: 8 maja 2026 r. Niniejsza Informacja o ochronie prywatności opisuje, w jaki sposób Praxis Precision Medicines, Inc. („my”, „nas”, „nasz”) gromadzi, wykorzystuje i ujawnia informacje o Tobie, gdy korzystasz z Praxis eDiary („Aplikacja”). Na potrzeby niniejszej Informacji o ochronie prywatności
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES INFORMATIVA SULLA PRIVACY DI PRAXIS eDIARY Ultimo aggiornamento: 8 maggio 2026 La presente Informativa sulla privacy descrive le modalità con cui Praxis Precision Medicines, Inc. (“noi”, “ci”, “nostro”) raccoglie, utilizza e divulga informazioni che La riguardano quando utilizza Praxis eDiary (“App”). Ai fini della presente Informativa sulla privacy, “Lei”, “La”
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINESהודעת פרטיות עבור PRAXIS eDIARYעודכן לאחרונה: 08 במאי 2026הודעת פרטיות זו מתארת כיצד Praxis Precision Medicines, Inc. (״אנו״, ״אותנו״, ״שלנו״) אוספת מידע עליך, משתמשת בו ומגלה אותו כאשר אתה משתמש ב-Praxis eDiary (״האפליקציה״). למטרות הודעת פרטיות זו, ״אתה״ ו״שלך״ פירושם אתה כמשתמש באפליקציה.הודעת פרטיות זו נועדה לעמוד בחובות מסירת המידע שלנו
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINESPRAXIS E-DIARY PRIVACY NOTICELast Updated: January 15, 2026This Privacy Notice describes how Praxis Precision Medicines Inc. (“we”, “us”, “our”) collects, uses and discloses information about you when you use our Praxis E-Diary (the “App”). For the purposes of this Privacy Notice, “you” and “your” means you as the user of the
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES ΔΗΛΩΣΗ ΑΠΟΡΡΗΤΟΥ PRAXIS eDIARY Τελευταία ενημέρωση: 8 Μαΐου 2026 Η παρούσα Δήλωση Απορρήτου περιγράφει τον τρόπο με τον οποίο η Praxis Precision Medicines, Inc. («εμείς», «εμάς», «μας») συλλέγει, χρησιμοποιεί και γνωστοποιεί πληροφορίες σχετικά με εσάς όταν χρησιμοποιείτε το Praxis eDiary (η «Εφαρμογή»). Για τους σκοπούς της παρούσας Δήλωσης Απορρήτου, οι
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES DATENSCHUTZHINWEIS ZUM PRAXIS eDIARY Zuletzt aktualisiert: 8. Mai 2026 Dieser Datenschutzhinweis beschreibt, wie Praxis Precision Medicines, Inc. („wir“, „uns“, „unser“) Informationen über Sie erhebt, verwendet und offenlegt, wenn Sie das Praxis eDiary (die „App“) nutzen. Für die Zwecke dieses Datenschutzhinweises beziehen sich „Sie“ und „Ihr“ auf Sie als Nutzer/in der
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES AVIS DE CONFIDENTIALITÉ PRAXIS eDIARY Dernière mise à jour : 8 mai 2026 Le présent Avis de confidentialité décrit la manière dont Praxis Precision Medicines, Inc. (« nous », « notre », « nos ») collecte, utilise et divulgue des informations vous concernant lorsque vous utilisez Praxis eDiary (l’« Application
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES PRIVACYVERKLARING PRAXIS eDIARY Laatst bijgewerkt: 8 mei 2026 Deze Privacyverklaring beschrijft hoe Praxis Precision Medicines, Inc. (“wij”, “ons”, “onze”) informatie over u verzamelt, gebruikt en bekendmaakt wanneer u Praxis eDiary (de “App”) gebruikt. Voor de doeleinden van deze Privacyverklaring betekenen “u” en “uw” u als gebruiker van de App. Deze
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINES PRIVACYVERKLARING PRAXIS eDIARY Laatst bijgewerkt: 8 mei 2026 In deze Privacyverklaring wordt beschreven hoe Praxis Precision Medicines, Inc. (“wij”, “ons”, “onze”) informatie over u verzamelt, gebruikt en openbaar maakt wanneer u Praxis eDiary (de “App”) gebruikt. Voor de doeleinden van deze Privacyverklaring betekenen “u” en “uw” u als gebruiker van
- [Privacy Notice - eDiary](https://praxismedicines.com/privacy-notice-ediary/) - Privacy Policy PRAXIS PRECISION MEDICINESOZNÁMENÍ O OCHRANĚ OSOBNÍCH ÚDAJŮ PRO APLIKACI PRAXIS eDIARYNaposledy aktualizováno: 8. května 2026Toto oznámení o ochraně osobních údajů popisuje, jak společnost Praxis Precision Medicines, Inc. („my“, „nás“, „naše“) shromažďuje, používá a zpřístupňuje informace o vás, když používáte aplikaci Praxis eDiary (dále jen „aplikace“). Pro účely tohoto oznámení o ochraně osobních údajů
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions CONDITIONS D’UTILISATION DE L’APPLICATION PRAXIS E-DIARYDernière révision le 14 janvier 2026Bienvenue dans les Conditions d’utilisation (les présentes « Conditions ») de l’application mobile Praxis E-Diary (l’« Application ») exploitée au nom de Praxis Precision Medicines Inc. (la « Société », « nous » ou « notre/nos »). L’Application et l’ensemble des contenus, outils, caractéristiques et fonctionnalités proposés sur ou via
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions SERVICEVOORWAARDEN PRAXIS E-DIARY APPLaatst herzien op 14 januari 2026Welkom bij de Servicevoorwaarden (deze “Voorwaarden”) voor de mobiele applicatie Praxis E-Diary (de “App”) die wordt beheerd namens Praxis Precision Medicines Inc. (“Bedrijf”, “wij” of “ons”). De App en alle inhoud, tools, functies en functionaliteit die op of via onze App worden aangeboden, worden
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions PODMÍNKY SLUŽBY APLIKACE PRAXIS eDIARYNaposledy revidováno 14. ledna 2026Vítejte v Podmínkách poskytování služeb (tyto „podmínky“) mobilní aplikace Praxis eDiary („aplikace“), která je provozována jménem společnosti Praxis Precision Medicines Inc. („společnost“, „my“ nebo „nás/nám“). Aplikace a veškerý obsah, nástroje, funkce a funkcionality nabízené v naší aplikaci nebo jejím prostřednictvím jsou společně označovány jako
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions PRAXIS E-DIARY APP TERMS OF SERVICELast Revised on January 14, 2026Welcome to the Terms of Service (these “Terms”) for the Praxis E-Diary mobile application (the “App”) operated on behalf of Praxis Precision Medicines Inc. (“Company”, “we” or “us”). The App and any content, tools, features and functionality offered on or through our
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions УМОВИ НАДАННЯ ПОСЛУГ ДОДАТКУ PRAXIS E-DIARY Дата останнього перегляду: 14 січня 2026 року Вітаємо в Умовах надання послуг (ці «Умови») мобільного додатку Praxis E-Diary («Додаток»), робота якого забезпечується від імені компанії Praxis Precision Medicines Inc. («Компанія», «ми» або «нас»). Додаток та будь-який контент, інструменти, функції та можливості, що пропонуються в нашому Додатку
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions PRAXIS E-DIARY UYGULAMASI HİZMET KOŞULLARI Son Revizyon Tarihi: 14 Ocak 2026 Praxis Precision Medicines Inc. (“Şirket“, “biz” veya “tarafımız“) adına işletilen Praxis E-Diary mobil uygulamasına (“Uygulama“) ilişkin Hizmet Koşullarına (bu “Koşullar“) hoş geldiniz. Uygulama ile Uygulamamız üzerinde veya Uygulamamız aracılığıyla sunulan her türlü içerik, araç, özellik ve işlevsellik toplu olarak “Hizmetler” olarak
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TÉRMINOS DE SERVICIO DE LA APLICACIÓN DE DIARIO ELECTRÓNICO DE PRAXIS Última revisión: 14 de enero de 2026 Le damos la bienvenida a los Términos de servicio (estos “Términos”) de la aplicación móvil de diario electrónico (la “Aplicación”) de Praxis operada en nombre de Praxis Precision Medicines Inc. (la “Compañía”, “nosotros” o “nos”). La
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TÉRMINOS DE SERVICIO DE LA APLICACIÓN DE DIARIO ELECTRÓNICO DE PRAXIS Última revisión: 14 de enero de 2026 Le damos la bienvenida a los Términos de servicio (estos «Términos») de la aplicación móvil de diario electrónico (la «Aplicación») de Praxis operada en nombre de Praxis Precision Medicines Inc. (la «Empresa», «nosotros» o «nos»). La
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions USLOVI KORIŠĆENJA APLIKACIJE PRAXIS E-DIARY Poslednji put revidirano 14. januara 2026. Dobro došli u Uslove korišćenja usluge (ovi „Uslovi”) za mobilnu aplikaciju Praxis E-Diary („Aplikacija”) kojom se upravlja u ime kompanije Praxis Precision Medicines Inc. („Kompanija”, „mi” ili „nas”). Aplikacija i sav sadržaj, alatke, funkcije i funkcionalnosti koje se nude u našoj
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions УСЛОВИЯ ПОЛЬЗОВАНИЯ ПРИЛОЖЕНИЕМ PRAXIS E-DIARY Последнее обновление: 14 января 2026 г. Добро пожаловать в Условия пользования (далее — «Условия») мобильным приложением Praxis E-Diary (далее — «Приложение») от Praxis Precision Medicines Inc. (далее — «Компания», «мы» или «нас»). Приложение и любой контент, инструменты, функции и возможности, предлагаемые в нашем Приложении или через него,
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TERMENII DE UTILIZARE AI APLICAȚIEI PRAXIS E-DIARY Ultima revizuire la 14 ianuarie 2026 Bun venit la Termenii de utilizare (acești „Termeni”) pentru aplicația mobilă Praxis E-Diary („Aplicația”) operată în numele Praxis Precision Medicines Inc. („Compania”, „noi” sau „nouă”). Aplicația și orice conținut, instrumente, caracteristici și funcționalități oferite pe sau prin intermediul aplicației
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TERMOS DE SERVIÇO DA APLICAÇÃO PRAXIS E-DIARY Última revisão a 14 de janeiro de 2026 Bem-vindo aos Termos de Serviço (estes “Termos”) da aplicação móvel Praxis E-Diary (a “Aplicação”) operada em nome da Praxis Precision Medicines Inc. (a “Empresa”, “nós” ou “nos”). A Aplicação e qualquer conteúdo, ferramentas, funcionalidades e características oferecidos
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TERMOS DE SERVIÇO DO APLICATIVO PRAXIS E-DIARY Última revisão em 14 de janeiro de 2026 Bem-vindo aos Termos de Serviço (estes “Termos”) do aplicativo móvel Praxis E-Diary (o “Aplicativo”) operado em nome da Praxis Precision Medicines Inc. (“Empresa”, “nós” ou “nos”). O Aplicativo e qualquer conteúdo, ferramentas, recursos e funcionalidades oferecidos em
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions WARUNKI ŚWIADCZENIA USŁUGI E-DZIENNICZEK (E-DIARY) PRZEZ FIRMĘ PRAXIS Ostatnia aktualizacja: 14 stycznia 2026 r. Przedstawiamy Warunki świadczenia usługi (niniejsze „Warunki”) aplikacji mobilnej Praxis E-Diary („Aplikacja”), w imieniu firmy Praxis Precision Medicines Inc. („Firma”, „my” lub „nas”). Aplikacja oraz wszelkie treści, narzędzia, funkcje i funkcjonalności oferowane w naszej Aplikacji lub za jej pośrednictwem
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions TERMINI DEL SERVIZIO DELL’APP PRAXIS E-DIARY Ultima revisione: 14 gennaio 2026 Benvenuti nei Termini di servizio (“Termini”) per l’applicazione mobile Praxis E-Diary (‘“App”) gestita per conto di Praxis Precision Medicines Inc. (“Società”, “noi” o “ci”). L’App e qualsiasi contenuto, strumento, caratteristica e funzionalità offerti su o tramite la nostra App sono collettivamente
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions תנאי שירות עבור אפליקציית PRAXIS E-DIARY עודכן לאחרונה ב-14 בינואר 2026 ברוכים הבאים לתנאי השירות (“תנאים” אלה) עבור האפליקציה לנייד Praxis E-Diary (“האפליקציה“) המופעלת מטעם .Praxis Precision Medicines Inc (“החברה“, “אנחנו” או “אותנו“). האפליקציה וכל תוכן, כלים, מאפיינים ופונקציונליות המוצעים באפליקציה שלנו או דרכה מכונים ביחד “השירותים“. תנאים אלה מסדירים את הגישה
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions ΟΡΟΙ ΠΑΡΟΧΗΣ ΥΠΗΡΕΣΙΩΝ ΤΗΣ ΕΦΑΡΜΟΓΗΣ PRAXIS E-DIARY Τελευταία αναθεώρηση στις 14 Ιανουαρίου 2026 Καλώς ορίσατε στους Όρους Παροχής Υπηρεσιών (αυτοί οι «Όροι») για την εφαρμογή κινητών συσκευών Praxis E-Diary (η «Εφαρμογή») που λειτουργεί για λογαριασμό της Praxis Precision Medicines Inc. (η «Εταιρεία», «εμείς» ή «εμάς»). Η Εφαρμογή και οποιοδήποτε περιεχόμενο, εργαλεία, δυνατότητες
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions SERVICEVOORWAARDEN VAN DE PRAXIS E-DIARY-APP Laatst herzien op 14 januari 2026 Welkom bij de Servicevoorwaarden (deze “Voorwaarden”) voor de mobiele applicatie Praxis E-Diary (de “App”) die wordt beheerd namens Praxis Precision Medicines Inc. (het “Bedrijf”, “wij” of “ons”). De App en alle inhoud, tools, functies en functionaliteit die op of via onze
- [Terms of Service - eDiary](https://praxismedicines.com/terms-of-service-ediary/) - Terms + Conditions NUTZUNGSBEDINGUNGEN FÜR DIE PRAXIS E-DIARY-APP Zuletzt überarbeitet am 14. Januar 2026 Willkommen bei den Nutzungsbedingungen (diese „Bedingungen“) für die mobile Anwendung Praxis E-Diary (die „App“), die im Auftrag von Praxis Precision Medicines Inc. („Unternehmen“, „wir“ oder „uns“) betrieben wird. Die App und alle Inhalte, Tools, Merkmale und Funktionen, die auf oder über
- [Publications](https://praxismedicines.com/publications/) - Publications Scientific Publications & Presentations Explore data from our clinical programs across central nervous system disorders, including movement disorders and epilepsy, supported by our precision neuroscience approach. Ulixacaltamide Relutrigine Vormatrigine Elsunersen Other 2026 AAN Annual Meeting Efficacy and Safety of Ulixacaltamide in Essential Tremor: Topline Phase 3 Results from Essential3 Study 1 (Parallel-Design Study) Maintenance
- [Privacy Policy](https://praxismedicines.com/privacy-policy/) - Privacy Policy PRAXIS PRECISION MEDICINES INC.PRIVACY POLICYLast Updated: May 19, 2022This Privacy Policy (“Privacy Policy”) describes the data protection practices of Praxis Precision Medicines Inc. and any affiliates (collectively, “Praxis,” “we,” “our,” or “us”), including when you visit a Praxis website that links to this Privacy Policy, such as including, but not limited to, www.praxismedicines.com (our
- [Expanded Access Policy](https://praxismedicines.com/eap/) - Expanded Access Policy Praxis Precision Medicines (Praxis) is dedicated to developing new therapies that have a positive impact on patient health, and to serving patients, patient families and patient communities through education, empathy, and awareness. Consistent with the Praxis mission to bring innovative medicines to patients with serious or life-threatening conditions, we are focused on
- [Terms + Conditions](https://praxismedicines.com/terms-conditions/) - Terms + Conditions PRAXIS PRECISION MEDICINES, INC. TERMS OF USELast updated: January 29, 2021These Terms of Use (“Terms”) are a legal contract between you and Praxis Precision Medicines, Inc., and our subsidiaries and affiliates (“us” or “our” or “we” or “Praxis”). These Terms govern your use of our website at https://praxismedicines.com and all related subdomains and
- [Stuart Arbuckle](https://praxismedicines.com/leadership/stuart-arbuckle/) - Board of Directors Stuart Arbuckle Director Stuart Arbuckle, has served as a member of our board of directors since January 2026. Mr. Arbuckle previously served as the Executive Vice President and Chief Operating Officer of Vertex Pharmaceuticals Incorporated, or Vertex, from August 2021 to July 2025, where he was responsible for the company’s global commercial team, portfolio and
- [Jeffrey Kindler](https://praxismedicines.com/leadership/jeffrey-kindler/) - Board of Directors Jeffrey Kindler Director Jeffrey Kindler, J.D., has served as a member of our board of directors since January 2026. Mr. Kindler has served as Chief Executive Officer of Centrexion Therapeutics Corp., a private biopharmaceutical company, since October 2013, and as Founding Partner and Co-Chair of the Pioneer Collective, a leadership accelerator for healthcare C-suite executives, since January 2024. He
- [Leadership](https://praxismedicines.com/leadership/) - Leadership Team We have attracted a talented team of scientists and researchers in genetics and biology, chemistry and translational medicine as well as business leaders with established track records of successfully executing innovative drug discovery and development programs. Marcio SouzaPresident & Chief Executive Officer Steve PetrouCo-Founder, President of Research & Development Alyssa WyantChief Regulatory &
- [Greg Norden](https://praxismedicines.com/leadership/greg-norden/) - Board of Directors Greg Norden Director Gregory Norden has served as a member of our board of directors since March 2019. Mr. Norden is the former Chief Financial Officer of Wyeth Pharmaceuticals Inc. and has served as the Managing Director of G9 Capital Group LLC, which invests in early stage ventures and provides corporate advisory services, since 2010.
- [Holger Lerche](https://praxismedicines.com/leadership/holger-lerche/) - Scientific Advisory Board Holger Lerche Member Holger Lerche is Professor of Neurology and Clinical Director of the Department of Neurology and Epileptology at the Hertie Institute for Clinical Brain Research, University and University Clinic of Tübingen, Germany. He studied medicine in Munich, did his MD and training in physiology and neurology in Ulm, and undertook
- [Ivan Soltesz](https://praxismedicines.com/leadership/ivan-soltesz/) - Scientific Advisory Board Ivan Soltesz Member Ivan Soltesz, PhD, is the James R. Doty Professor of Neurosurgery and Neurosciences at Stanford University School of Medicine. Dr. Soltesz has over 30 years of research experience, with his work focusing on understanding the nature of neuronal inhibition in the brain and the mechanistic bases of circuit dysfunction
- [William Young](https://praxismedicines.com/leadership/william-young/) - Board of Directors William Young Director William Young has served as a member of our board of directors since December 2016. Mr. Young is an Executive Advisor with Blackstone Life Sciences, which he joined in November 2018. Prior to its acquisition by Blackstone, Mr. Young joined Clarus Ventures LLC in March 2010 and held various roles,
- [Tim Kelly](https://praxismedicines.com/leadership/tim-kelly/) - Executive Team Tim Kelly Chief Financial Officer Tim Kelly has served as our Chief Financial Officer since May 2021. Prior to joining us, Mr. Kelly was at Foundation Medicine, where he served as chief financial officer and head of corporate management from January 2019 to April 2021. In this position, he led the finance and
- [Steven Petrou](https://praxismedicines.com/leadership/steven-petrou/) - Executive Team Steven Petrou Co-Founder, President of Research & Development Steven Petrou, Ph.D., is a co-founder of the company and has served as our President of Research & Development since January 2026. Previously, he served as our Chief Scientific Officer from January 2018 to December 2025. Dr. Petrou is currently the Head of the Ion
- [Sam Berkovic](https://praxismedicines.com/leadership/sam-berkovic/) - Scientific Advisory Board Sam Berkovic Member Sam Berkovic is Laureate Professor in the Department of Medicine, University of Melbourne, and Director of the Epilepsy Research Centre at Austin Health, Australia.His early work was in neuroimaging where he was a pioneer in the application of MRI and single photon emission computed tomography in epilepsy. This work
- [Nicole Sweeny](https://praxismedicines.com/leadership/nicole-sweeny/) - Executive Team Nicole Sweeny Chief Commercial Officer Nicole Sweeny has served as our Chief Commercial Officer since August 2020. Prior to joining us, Ms. Sweeny was at Takeda Pharmaceuticals, where she served as Vice President, Franchise Head, Rare Diseases from February 2019 to July 2020. Prior to Takeda, Ms. Sweeny served in several roles at
- [Megan Sniecinski](https://praxismedicines.com/leadership/megan-sniecinski/) - Executive Team Megan Sniecinski Chief Operating Officer Megan Sniecinski has served as our Chief Operating Officer since January 2026. Previously, she served as our Chief Business Officer from December 2021 to December 2025. Prior to joining us, she served as Chief Business Officer at BioCryst Pharmaceuticals from July 2019 to August 2021, overseeing corporate development, global medical affairs, program management and
- [Matt Might](https://praxismedicines.com/leadership/matt-might/) - Board of Directors Matt Might Chairman of the Scientific Advisory Board Dr. Matthew Might has been the Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham (UAB) since 2017. At UAB, Dr. Might is the Hugh Kaul Precision Medicine Institute Endowed Chair, a Professor of Internal Medicine and a Professor of Computer
- [Marcio Souza](https://praxismedicines.com/leadership/marcio-souza/) - Executive Team Marcio Souza President and Chief Executive Officer Marcio Souza has served as our President and Chief Executive Officer and a member of our board of directors since April 2020. Prior to joining us, Mr. Souza was at PTC Therapeutics, Inc. (PTC), where he served as its Chief Operating Officer from May 2017 to April
- [Kelly McCue](https://praxismedicines.com/leadership/kelly-mccue/) - Executive Team Kelly McCue Chief People Officer Kelly McCue has served as our Chief People Officer since December 2020. Prior joining us, Ms. McCue was at Valmet, Inc., where she served as Vice President, Human Resources Operations from July 2019 to December 2020 its Vice President, Human Resources for their Services Business Line from 2013
- [Karl Hansen](https://praxismedicines.com/leadership/karl-hansen/) - Executive Team Karl Hansen Chief Technical Operations Officer Karl Hansen, Ph.D., has served as Chief Technical Operations Officer since December 2021. Previously, he served as our Senior Vice President of CMC from May 2020 to November 2021. Prior to joining us, Dr. Hansen was at Boston Pharmaceuticals, where he served as Vice President, CMC from
- [Jill Desimone](https://praxismedicines.com/leadership/jill-desimone/) - Board of Directors Jill Desimone Director Jill DeSimone has served as a member of our board of directors since May 2022. Ms. DeSimone served as President of U.S. Oncology at Merck & Co., Inc., or Merck, from 2014 to May 2022. During her time at Merck, Ms. DeSimone also temporarily served as Interim President of U.S.
- [Dr. Merit Cudkowicz](https://praxismedicines.com/leadership/dr-merit-cudkowicz/) - Board of Directors Dr. Merit Cudkowicz Director Merit Cudkowicz, M.D., has served as a member of our board of directors since April 2021. Dr. Cudkowicz has served as the inaugural Executive Director of the Massachusetts General Brigham Neuroscience Institute since February 2025. She previously served as the Chair of Neurology at Massachusetts General Hospital from 2012 to January 2025.
- [Dr. Jeff Chodakewitz](https://praxismedicines.com/leadership/dr-jeff-chodakewitz/) - Board of Directors Dr. Jeff Chodakewitz Director Jeffrey Chodakewitz, M.D., has served as a member of our board of directors since April 2021. Dr. Chodakewitz has served as an advisory partner for Ascenta Capital, a life sciences investment firm, since December 2022. He previously served as a senior advisor to Blackstone Life Sciences, a life sciences private equity firm from March 2019 to
- [Dean Mitchell](https://praxismedicines.com/leadership/dean-mitchell/) - Board of directors Dean Mitchell Chairman of the Board Dean Mitchell has served as chairman of our board of directors since September 2020. He served as executive chairman of the board of directors of Covis Pharma Holdings S.à.r.l., a specialty pharmaceutical company, from August 2013 until its sale in March 2020 and was chairman of PaxVax Corporation from January 2016 until its sale
- [Brian Spar](https://praxismedicines.com/leadership/brian-spar/) - Executive Team Brian Spar Chief of Staff Brian Spar has served as Chief of Staff since March 2022 and leads our rare epilepsy development teams. Prior to joining us, Mr. Spar was at BioCryst Pharmaceuticals where he served as Vice President, Head of Program Management. Prior to joining BioCryst, he held multiples positions at PTC Therapeutics including Chief
- [Anna Greka](https://praxismedicines.com/leadership/anna-greka/) - Scientific Advisory Board Anna Greka Member Anna Greka is a Professor of Medicine at Harvard Medical School, a physician at Brigham and Women’s Hospital, and an Institute Member of the Broad Institute of MIT and Harvard, where she serves on the Executive Leadership Team.Seeking to lay the foundation for molecularly targeted therapies, Anna leads a
- [Alyssa Wyant](https://praxismedicines.com/leadership/alyssa-wyant/) - Executive Team Alyssa Wyant Chief Regulatory & Quality Officer Alyssa Wyant has served as our Chief Regulatory and Quality Officer since December 2021. Previously, she served as Senior Vice President of Regulatory and Quality from September 2020 to November 2021. Prior to joining us, Ms. Wyant was at EryDel S.p.A, where she served as Senior
- [Alex Nemiroff](https://praxismedicines.com/leadership/alex-nemiroff/) - Executive Team Alex Nemiroff General Counsel Alex Nemiroff, J.D., has served as our General Counsel since June 2020. Prior to his role as General Counsel, Mr. Nemiroff served as our Vice President of Legal from January 2020 to June 2020. Mr. Nemiroff was also a co-founder of RogCon, Inc. and RogCon U.R., Inc., and he
- [36th International Epilepsy Congress - Meeting Follow Up](https://praxismedicines.com/iec2025meeting-followup/) - Meeting Recap from the 36th Annual International Epilepsy Congress August 30, 2025 – September 3, 2025,Lisbon Portugal Missed us at IEC 2025 and want to connect? Share your details below and we’ll be in touch to arrange a discussion with our leadership team. Area of Interest Developmental and epileptic encephalopathies (DEEs) Focal/generalized epilepsy By submitting
- [36th International Epilepsy Congress - Resource](https://praxismedicines.com/iec2025meeting-resources/) - Meet Us at the 36th International Epilepsy Congress August 30, 2025 – September 3, 2025,Lisbon Portugal | Booth #435 Schedule time with our team to discuss recent updates including positive topline data from the RADIANT study Date Preference Sunday, August 31 Monday, September 1 Tuesday, September 2 Time of Day Preference Early Morning Late Morning
- [36th International Epilepsy Congress - Book](https://praxismedicines.com/iec2025meeting-book/) - Meet Us at the 36th International Epilepsy Congress August 30, 2025 – September 3, 2025,Lisbon Portugal | Booth #435 Schedule time with our team to discuss recent updates including positive topline data from the RADIANT study Date Preference Sunday, August 31 Monday, September 1 Tuesday, September 2 Time of Day Preference Early Morning Late Morning
- [36th International Epilepsy Congress](https://praxismedicines.com/iec2025meeting/) - Meet Us at the 36th InternationalEpilepsy Congress August 30, 2025 – September 3, 2025,Lisbon Portugal | Booth #435 Stop by our booth and scientific exhibit to explore our leading precision epilepsy programs. Don’t miss the chance to test your knowledge in the Exhibition Quiz! Presenting Updates from Our Leading Portfolio of Epilepsy Programs We are
- [Contact](https://praxismedicines.com/contact/) - Contact Us 99 High Street 30th Floor Boston, MA 02110 contact@praxismedicines.com careers@praxismedicines.com Email Message Submit
- [2025 AAN Annual Meeting](https://praxismedicines.com/aanannualmeeting/) - 2025 AAN Annual Meeting 2025 AAN Annual Meeting April 5-9, San Diego Convention Center | Booth #2113 April 5-9, San Diego Convention Center, Booth #2113 Join us in our booth for drinks and appetizers during the Exhibitor Networking Crawl! Join us in our booth for drinks and appetizers during theExhibitor Networking Crawl! Monday, April 7th